11
Participants
Start Date
December 15, 2020
Primary Completion Date
December 31, 2023
Study Completion Date
December 16, 2024
Nasal Delivery of High-Flow Air and Oxygen Therapy
They will receive high-flow air and oxygen via a dual lumen nasal cannula at rest. Participants will be administered the high-flow air and then titrated with oxygen from 0 L/min until they reach and maintain a SpO2 level of 95% for 30 seconds. They will then remain on this setting for 3 additional minutes with continuous monitoring of SpO2 levels.
Nasal Delivery of Oxygen Therapy
They will receive oxygen via a dual lumen nasal cannula at rest. Participants will be titrated with oxygen from 0 L/min until they reach and maintain a SpO2 level of 95% for 30 seconds. They will then remain on this setting for 3 additional minutes with continuous monitoring of SpO2 levels.
Johns Hopkins Hospital Bayview Asthma and Allergy Center, Baltimore
The Johns Hopkins Hospital, Baltimore
American College of Chest Physicians
OTHER
Johns Hopkins University
OTHER